Individual generic drug information

finerenone

Reference monograph

Part of registered formulation

FINERENONE

Reference record: finerenone
Source: Mosby’s 2024 Nursing Drug Reference
Printed source pages: 564
Age groups indexed: Not recorded

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for finerenone only.

Names and pronunciation

(fin-ER-e-none) Kerendia

Source page 564

Functional class

Func. class.: Nonsteroidal, mineralo- corticoid antagonist

Source page 564

Uses

USES: Chronic kidney disease associ- ated with type 2 diabetes DOSAGES AND ROUTES • Adult: PO 10 or 20 mg daily based on eGFR

Source page 564

Dose and formulations

Extracted information for finerenone only.

Available forms

Available forms: Tabs 10, 20 mg

Source page 564

Dose text by age group

Filter the extracted dose blocks for this individual drug.

No dose block was identified for this age filter. This does not establish whether the drug is suitable for that age group.

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.

Individual generic drug information

finerenone

Reference monograph

Part of registered formulation

FINERENONE

Reference record: finerenone
Source: Mosby’s 2024 Nursing Drug Reference
Printed source pages: 564
Age groups indexed: Not recorded

Individual active ingredientSource records are displayed separately

Some source sections could not be separated reliably in the extraction. Review the printed source pages when a field is missing or incomplete.

Overview

Extracted information for finerenone only.

Names and pronunciation

(fin-ER-e-none) Kerendia

Source page 564

Functional class

Func. class.: Nonsteroidal, mineralo- corticoid antagonist

Source page 564

Uses

USES: Chronic kidney disease associ- ated with type 2 diabetes DOSAGES AND ROUTES • Adult: PO 10 or 20 mg daily based on eGFR

Source page 564

Dose and formulations

Extracted information for finerenone only.

Available forms

Available forms: Tabs 10, 20 mg

Source page 564

Dose text by age group

Filter the extracted dose blocks for this individual drug.

No dose block was identified for this age filter. This does not establish whether the drug is suitable for that age group.

Age labels are extracted from the printed dose headings and require clinical review. Confirm current local guidance, dose, route, formulation, contraindications and interactions before prescribing.